Revelation Biosciences, Inc. – NASDAQ:REVBW

Add to watchlist

$0.014

+0.00

+58.43%

Market closed

Open in 3 days

-24.68%

month

-24.68%

quarter

-26.23%

year

Market Cap	2.69M
Enterprise value	N/A

P/E	-0.01
EV/Sales	N/A
EV/EBITDA	N/A
Price/Sales	N/A
Price/Book	0.31
PEG ratio	N/A
EPS	-30.94

Revenue	N/A
EBITDA	-9.42M
Income	-8.96M
Revenue Q/Q	N/A
Revenue Y/Y	N/A

Profit margin	0%
Oper. margin	0%
Gross margin	0%
EBIT margin	0%
EBITDA margin	N/A

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Revelation Biosciences, Inc. (NASDAQ:REVBW): Profit margin
Jun 2023	0	-1.44M
Sep 2023	0	-2.62M
Dec 2023	37.57K	-2.20M	-5862.84%
Mar 2024	0	-2.68M

Revelation Biosciences, Inc. (NASDAQ:REVBW): Debt to assets
Jun 2023	16038838	4.62M	28.83%
Sep 2023	14218520	5.39M	37.98%
Dec 2023	12212609	5.56M	45.57%
Mar 2024	14701610	5.22M	35.56%

Revelation Biosciences, Inc. (NASDAQ:REVBW): Cash Flow
Jun 2023	-1.99M	0	15
Sep 2023	-1.71M	0	0
Dec 2023	-2.00M	0	0
Mar 2024	-2.83M	-19.17K	5.41M

Revelation Biosciences alternative data

Revelation Biosciences
Employees

Revelation Biosciences, Inc. (NASDAQ:REVBW): Employee count
Jan 2024	6
Feb 2024	6
Mar 2024	9
Apr 2024	9
May 2024	9
Jun 2024	9
Jul 2024	9

Revelation Biosciences
Hedge Funds Holdings Q1 2023

100.00% +91.45%

of REVBW is owned by hedge funds

8 -2

hedge funds hold REVBW stock

664.27K -1.13M

shares is hold by hedge funds

REVBW hedge funds holdings changes

Revelation Biosciences
Insider Trading

Revelation Biosciences, Inc. (NASDAQ:REVBW): Insider trades (number of shares)
Period	Buy	Sel
Sep 2021	0	654546
Feb 2022	103000	0

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Purchase	25 Feb 2022	TIDMARSH GEORGE F director, 10 percent owner director, 10 percent owner	Common Stock	20,000	$1.6	$32,000
Purchase	9 Feb 2022	TIDMARSH GEORGE F director, 10 percent owner director, 10 percent owner	Common Stock	30,000	$2.55	$76,590
Purchase	8 Feb 2022	TIDMARSH GEORGE F director, 10 percent owner director, 10 percent owner	Common Stock	1,000	$2.54	$2,540
Purchase	7 Feb 2022	TIDMARSH GEORGE F director, 10 percent owner director, 10 percent owner	Common Stock	42,100	$2.61	$109,797
Purchase	4 Feb 2022	TIDMARSH GEORGE F director, 10 percent owner director, 10 percent owner	Common Stock	7,900	$2.31	$18,257
Purchase	4 Feb 2022	TIDMARSH GEORGE F director, 10 percent owner director, 10 percent owner	Common Stock	2,000	$2.45	$4,900
Sale	23 Sep 2021	GLAZER CAPITAL, LLC 10 percent owner 10 percent owner	Common stock, $0.001 par value per share	611,541	$10.08	$6,164,333
Sale	22 Sep 2021	GLAZER CAPITAL, LLC 10 percent owner 10 percent owner	Common stock, $0.001 par value per share	5	$10.08	$50
Sale	21 Sep 2021	GLAZER CAPITAL, LLC 10 percent owner 10 percent owner	Common stock, $0.001 par value per share	43,000	$10.08	$433,440
Sale	9 Nov 2020	GLAZER CAPITAL, LLC 10 percent owner 10 percent owner	Units	5,000	$10	$50,000

REVBW insider trading transactions

Frequently Asked Questions (FAQ)

What's the price of Revelation Biosciences stock today?

One share of Revelation Biosciences stock can currently be purchased for approximately $0.01.
When is Revelation Biosciences's next earnings date?

Unfortunately, Revelation Biosciences's (REVBW) next earnings date is currently unknown.
Does Revelation Biosciences pay dividends?

No, Revelation Biosciences does not pay dividends.
How much money does Revelation Biosciences make?

Revelation Biosciences has a market capitalization of 2.69M.
What is Revelation Biosciences's stock symbol?

Revelation Biosciences, Inc. is traded on the NASDAQ under the ticker symbol "REVBW".
What is Revelation Biosciences's primary industry?

Company operates in the Healthcare sector and Biotechnology industry.
How do i buy shares of Revelation Biosciences?

Shares of Revelation Biosciences can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
How many employees does Revelation Biosciences have?

As Jul 2024, Revelation Biosciences employs 9 workers.
What is Revelation Biosciences's official website?

The official website for Revelation Biosciences is revbiosciences.com.
Where are Revelation Biosciences's headquarters?

Revelation Biosciences is headquartered at 5 West 21st Street, New York, NY.
How can i contact Revelation Biosciences?

Revelation Biosciences's mailing address is 5 West 21st Street, New York, NY and company can be reached via phone at +91 76225800.

Revelation Biosciences, Inc.

revbiosciences.com

Exchange:

NASDAQ

Full time employees:

Industry:

Biotechnology

Sector:

Healthcare

Revelation Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of immunologic-based therapeutics and diagnostics for the prevention and treatment of disease. The company's lead therapeutic candidate is REVTx-99, an intranasal immunomodulator to prevent or treat infections caused by various respiratory viruses, such as SARS-CoV-2 comprising its variants, influenza A and B, parainfluenza, rhinovirus, and RSV, as well as is being developed for other indications comprising allergic rhinitis and chronic nasal congestion. It also develops REVTx-200, an intranasal immunomodulator adjunct to be used in combination with an intramuscular vaccination for immunity; and REVDx-501, a rapid home use diagnostic to detect respiratory viral infection. The company was founded in 2019 and is based in New York, New York.

+91 76225800

5 West 21st Street
New York, NY 10010

CIK: 0001810560
ISIN: US76135L1199
CUSIP: 76135L119